Petr Ďulíček

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev et al. · The Lancet Haematology · 2020 · 327 citations

Polycythaemia Vera, Hematology, Clinical Trials +5

Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study

Francesco Dentali, Daniela Poli, Umberto Scoditti et al. · Journal of Thrombosis and Haemostasis · 2012 · 158 citations · Full text

Thrombosis, Venous Thrombosis, Ischemic Stroke +12

Oral Contraceptives and Venous Thromboembolism

Robert L. Reid, Carolyn Westhoff, Diana Mansour et al. · Journal of Family Planning and Reproductive Health Care · 2010 · 56 citations · Full text

Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases

Milan R. Voško, Christof Bocksrucker, Rafał Drwiła et al. · Journal of Thrombosis and Thrombolysis · 2017 · 56 citations · Full text

Patient Safety, Emergency Situations, Real-life Experience +4

Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use

Petr Ďulíček, E.Y. Ivanova, Milan Košťál et al. · Clinical and Applied Thrombosis/Hemostasis · 2017 · 45 citations · Full text

Contraceptive Use, Hormonal Contraceptive, Oral Contraceptive +28